Ignite Creation Date:
2025-12-25 @ 12:40 AM
Ignite Modification Date:
2026-04-15 @ 1:05 AM
Study NCT ID:
NCT03370367
Status:
COMPLETED
Last Update Posted:
2023-06-15
First Post:
2017-12-07
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Double Blind Phase III Trial of Effects of Low Dose 13-Cisretinoic Acid on Prevention of Second Primaries in Stages I-II Head and Neck Cancer
Sponsor:
Eastern Cooperative Oncology Group
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
1989-05-15
Start Date Type:
ACTUAL
Primary Completion Date:
1999-01-15
Primary Completion Date Type:
ACTUAL
Completion Date:
2015-04-14
Completion Date Type:
ACTUAL
First Submit Date:
2017-12-07
First Submit QC Date:
None
Study First Post Date:
2017-12-12
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-06-13
Last Update Post Date:
2023-06-15
Last Update Post Date Type:
ACTUAL